174 related articles for article (PubMed ID: 35642938)
1. Nanomaterial Inhalation During Pregnancy Alters Systemic Vascular Function in a Cyclooxygenase-Dependent Manner.
Griffith JA; Garner KL; Bowdridge EC; DeVallance E; Schafner KJ; Engles KJ; Batchelor TP; Goldsmith WT; Wix K; Hussain S; Nurkiewicz TR
Toxicol Sci; 2022 Jul; 188(2):219-233. PubMed ID: 35642938
[TBL] [Abstract][Full Text] [Related]
2. Maternal nano-titanium dioxide inhalation alters fetoplacental outcomes in a sexually dimorphic manner.
Griffith JA; Dunn A; DeVallance E; Schafner KJ; Engles KJ; Batchelor TP; Goldsmith WT; Wix K; Hussain S; Bowdridge EC; Nurkiewicz TR
Front Toxicol; 2023; 5():1096173. PubMed ID: 36950144
[TBL] [Abstract][Full Text] [Related]
3. Maternal Engineered Nanomaterial Inhalation During Gestation Disrupts Vascular Kisspeptin Reactivity.
Bowdridge EC; Abukabda AB; Engles KJ; McBride CR; Batchelor TP; Goldsmith WT; Garner KL; Friend S; Nurkiewicz TR
Toxicol Sci; 2019 Jun; 169(2):524-533. PubMed ID: 30843041
[TBL] [Abstract][Full Text] [Related]
4. Nano-titanium dioxide inhalation exposure during gestation drives redox dysregulation and vascular dysfunction across generations.
Bowdridge EC; DeVallance E; Garner KL; Griffith JA; Schafner K; Seaman M; Engels KJ; Wix K; Batchelor TP; Goldsmith WT; Hussain S; Nurkiewicz TR
Part Fibre Toxicol; 2022 Mar; 19(1):18. PubMed ID: 35260159
[TBL] [Abstract][Full Text] [Related]
5. Maternal Nanomaterial Inhalation Exposure: Critical Gestational Period in the Uterine Microcirculation is Angiotensin II Dependent.
Garner KL; Bowdridge EC; Griffith JA; DeVallance E; Seman MG; Engels KJ; Groth CP; Goldsmith WT; Wix K; Batchelor TP; Nurkiewicz TR
Cardiovasc Toxicol; 2022 Feb; 22(2):167-180. PubMed ID: 35066857
[TBL] [Abstract][Full Text] [Related]
6. Maternal titanium dioxide nanomaterial inhalation exposure compromises placental hemodynamics.
Abukabda AB; Bowdridge EC; McBride CR; Batchelor TP; Goldsmith WT; Garner KL; Friend S; Nurkiewicz TR
Toxicol Appl Pharmacol; 2019 Mar; 367():51-61. PubMed ID: 30711534
[TBL] [Abstract][Full Text] [Related]
7. Sex-specific differences in the mechanisms for enhanced thromboxane A
Graton ME; Spaans F; He R; Chatterjee P; Kirschenman R; Quon A; Phillips TJ; Case CP; Davidge ST
Biol Sex Differ; 2024 Jun; 15(1):52. PubMed ID: 38898532
[TBL] [Abstract][Full Text] [Related]
8. Group II innate lymphoid cells and microvascular dysfunction from pulmonary titanium dioxide nanoparticle exposure.
Abukabda AB; McBride CR; Batchelor TP; Goldsmith WT; Bowdridge EC; Garner KL; Friend S; Nurkiewicz TR
Part Fibre Toxicol; 2018 Nov; 15(1):43. PubMed ID: 30413212
[TBL] [Abstract][Full Text] [Related]
9. Maternal engineered nanomaterial exposure and fetal microvascular function: does the Barker hypothesis apply?
Stapleton PA; Minarchick VC; Yi J; Engels K; McBride CR; Nurkiewicz TR
Am J Obstet Gynecol; 2013 Sep; 209(3):227.e1-11. PubMed ID: 23643573
[TBL] [Abstract][Full Text] [Related]
10. Development of coronary dysfunction in adult progeny after maternal engineered nanomaterial inhalation during gestation.
Fournier SB; Lam V; Goedken MJ; Fabris L; Stapleton PA
Sci Rep; 2021 Sep; 11(1):19374. PubMed ID: 34588535
[TBL] [Abstract][Full Text] [Related]
11. Effect of Gestational Age on Maternofetal Vascular Function Following Single Maternal Engineered Nanoparticle Exposure.
Fournier SB; Kallontzi S; Fabris L; Love C; Stapleton PA
Cardiovasc Toxicol; 2019 Aug; 19(4):321-333. PubMed ID: 30734150
[TBL] [Abstract][Full Text] [Related]
12. Maternal, placental, and fetal distribution of titanium after repeated titanium dioxide nanoparticle inhalation through pregnancy.
D'Errico JN; Doherty C; Reyes George JJ; Buckley B; Stapleton PA
Placenta; 2022 Apr; 121():99-108. PubMed ID: 35305398
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary particulate matter and systemic microvascular dysfunction.
Nurkiewicz TR; Porter DW; Hubbs AF; Stone S; Moseley AM; Cumpston JL; Goodwill AG; Frisbee SJ; Perrotta PL; Brock RW; Frisbee JC; Boegehold MA; Frazer DG; Chen BT; Castranova V;
Res Rep Health Eff Inst; 2011 Dec; (164):3-48. PubMed ID: 22329339
[TBL] [Abstract][Full Text] [Related]
14. Elevated testosterone levels during rat pregnancy cause hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in uterine arteries.
Chinnathambi V; Blesson CS; Vincent KL; Saade GR; Hankins GD; Yallampalli C; Sathishkumar K
Hypertension; 2014 Aug; 64(2):405-14. PubMed ID: 24842922
[TBL] [Abstract][Full Text] [Related]
15. Effects of low-dose aspirin on maternal blood pressure and vascular function in an experimental model of gestational hypertension.
Osikoya O; Jaini PA; Nguyen A; Valdes M; Goulopoulou S
Pharmacol Res; 2017 Jun; 120():267-278. PubMed ID: 28412461
[TBL] [Abstract][Full Text] [Related]
16. Maternal-engineered nanomaterial exposure disrupts progeny cardiac function and bioenergetics.
Hathaway QA; Nichols CE; Shepherd DL; Stapleton PA; McLaughlin SL; Stricker JC; Rellick SL; Pinti MV; Abukabda AB; McBride CR; Yi J; Stine SM; Nurkiewicz TR; Hollander JM
Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H446-H458. PubMed ID: 28011589
[TBL] [Abstract][Full Text] [Related]
17. Maternal engineered nanomaterial inhalation during gestation alters the fetal transcriptome.
Stapleton PA; Hathaway QA; Nichols CE; Abukabda AB; Pinti MV; Shepherd DL; McBride CR; Yi J; Castranova VC; Hollander JM; Nurkiewicz TR
Part Fibre Toxicol; 2018 Jan; 15(1):3. PubMed ID: 29321036
[TBL] [Abstract][Full Text] [Related]
18. Exposure to stimulatory CpG oligonucleotides during gestation induces maternal hypertension and excess vasoconstriction in pregnant rats.
Goulopoulou S; Wenceslau CF; McCarthy CG; Matsumoto T; Webb RC
Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H1015-25. PubMed ID: 26873968
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous Vascular Bed Responses to Pulmonary Titanium Dioxide Nanoparticle Exposure.
Abukabda AB; Stapleton PA; McBride CR; Yi J; Nurkiewicz TR
Front Cardiovasc Med; 2017; 4():33. PubMed ID: 28596957
[TBL] [Abstract][Full Text] [Related]
20. Maternal exposure to nanosized titanium dioxide suppresses embryonic development in mice.
Hong F; Zhou Y; Zhao X; Sheng L; Wang L
Int J Nanomedicine; 2017; 12():6197-6204. PubMed ID: 28883729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
